Verdiva Bio Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 43

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $411M

  • Investors
  • 7

Verdiva Bio General Information

Description

Developer of next-generation therapies designed to help people living with obesity, cardiometabolic disorders, and related complications. The company accelerates the development of differentiated medicines that address unmet medical needs in gut-brain biology and include multiple amylin molecules, enabling users to access the potential for enhanced efficacy, improved tolerability, and healthier weight loss.

Contact Information

Formerly Known As
Mnco Bio Limited
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 25 Austen Road
  • Guildford GU1 3NP
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 25 Austen Road
  • Guildford GU1 3NP
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Verdiva Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 09-Jan-2025 $411M Completed Clinical Trials - Phase 2
To view Verdiva Bio’s complete valuation and funding history, request access »

Verdiva Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Verdiva Bio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Forbion Venture Capital Minority
General Atlantic Growth/Expansion Minority
LAV (Lilly Asia Fund) Corporate Venture Capital Minority
Logos Capital Hedge Fund Minority
LYFE Capital PE/Buyout Minority
You’re viewing 5 of 7 investors. Get the full list »

Verdiva Bio FAQs

  • When was Verdiva Bio founded?

    Verdiva Bio was founded in 2024.

  • Where is Verdiva Bio headquartered?

    Verdiva Bio is headquartered in Guildford, United Kingdom.

  • What is the size of Verdiva Bio?

    Verdiva Bio has 43 total employees.

  • What industry is Verdiva Bio in?

    Verdiva Bio’s primary industry is Drug Discovery.

  • Is Verdiva Bio a private or public company?

    Verdiva Bio is a Private company.

  • What is Verdiva Bio’s current revenue?

    The current revenue for Verdiva Bio is .

  • How much funding has Verdiva Bio raised over time?

    Verdiva Bio has raised $411M.

  • Who are Verdiva Bio’s investors?

    Forbion, General Atlantic, LAV (Lilly Asia Fund), Logos Capital, and LYFE Capital are 5 of 7 investors who have invested in Verdiva Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process